Cell MedX Corp.
Cell MedX Corp.
Share · US15115X1072 (OTC)
Overview
No Price
n/a
Company Profile for Cell MedX Corp. Share
Cell MedX Corp., a biotech company, focuses on the discovery, development, and commercialization of therapeutic and non-therapeutic products for patients with diabetes, Parkinson's disease, high blood pressure, neuropathy, and kidney functions. It develops and manufactures eBalance Pro System for professional use by healthcare practitioners in a clinical setting; and eBalance Home System for home use for general wellness and pain management treatment, which are controlled by the eBalance Console that acts as the central controller for three pre-programmed microcurrent algorithms, including wellness, pain management, and dual. The company was formerly known as Sports Asylum, Inc. and changed its name to Cell MedX Corp. in September 2014. Cell MedX Corp. was incorporated in 2010 and is based in Carson City, Nevada.
Get up to date insights from finAgent about Cell MedX Corp.

Company Data

Name Cell MedX Corp.
Company Cell MedX Corp.
Website https://www.cellmedx.com
Primary Exchange OTC UTC
ISIN US15115X1072
Asset Class Share
Sector Healthcare
Industry Medical - Devices
CEO David M. Jeffs
Market Capitalization 126 Mio
Country United States of America
Currency USD
Employees -
Address 123 West Nye Ln, 89706 Carson City
IPO Date 2013-08-29

Ticker Symbols

Name Symbol
Over The Counter CMXC
More Shares
Investors who hold Cell MedX Corp. also have the following shares in their portfolio:
AGEAS SA/NV
AGEAS SA/NV Share
SSGA Active Trust SPDR SSGA US Equity Premium Income ETF
SSGA Active Trust SPDR SSGA US Equity Premium Income ETF ETF
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025